価格表

在庫・価格 : 2025年10月08日 09時00分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Mouse CXCL13/BLC/BCA-1 MAb (Clone 143614)
データシート※最新のデータシートでない場合があります
MAB470-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥25,000
(未発注)
追加

在庫・価格 : 2025年10月08日 09時00分 現在

Anti-Mouse CXCL13/BLC/BCA-1 MAb (Clone 143614)

  • 商品コード:MAB470-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥25,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zhang M et al. Response patterns of cytokines/chemokines in two murine strains after irradiation. Cytokine 2012 May;58(2):169-77
Zhang M et al
2012/01/01
Species: Mouse, Applications: Luminex Development PubMed
2 Weisel FJ et al. Unique requirements for reactivation of virus-specific memory B lymphocytes. J. Immunol. 2010 Oct;185(7):4011-21
Weisel FJ et al
2010/01/01
Species: Mouse, Applications: Neutralization PubMed
3 Le坦n B et al. Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat. Immunol. 2012 Jul;13(7):681-90
Le坦n B et al
2012/01/01
Species: Mouse, Applications: Neutralization PubMed
4 Klimatcheva E et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol. 2015;16:6
Klimatcheva E et al
2015/01/01
PubMed
5 Kramer JM et al. CXCL13 is elevated in Sjögrens syndrome in mice and humans and is implicated in disease pathogenesis. J. Leukoc. Biol. 2013 Nov;94(5):1079-89
Kramer JM et al
2013/01/01
Species: Mouse, Applications: Neutralization PubMed
6 Thomas SN et al. Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J. Immunol. 2012 Sep;189(5):2181-90
Thomas SN et al
2012/01/01
Species: Mouse, Applications: IHC-Fr PubMed
  • No.: 1
  • 文献情報:
    Zhang M et al. Response patterns of cytokines/chemokines in two murine strains after irradiation. Cytokine 2012 May;58(2):169-77
    Zhang M et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: Luminex Development
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Weisel FJ et al. Unique requirements for reactivation of virus-specific memory B lymphocytes. J. Immunol. 2010 Oct;185(7):4011-21
    Weisel FJ et al
    2010/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Le坦n B et al. Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat. Immunol. 2012 Jul;13(7):681-90
    Le坦n B et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Klimatcheva E et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol. 2015;16:6
    Klimatcheva E et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kramer JM et al. CXCL13 is elevated in Sjögrens syndrome in mice and humans and is implicated in disease pathogenesis. J. Leukoc. Biol. 2013 Nov;94(5):1079-89
    Kramer JM et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Thomas SN et al. Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J. Immunol. 2012 Sep;189(5):2181-90
    Thomas SN et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr
  • 参照:
    PubMed